Sentence examples for in incremental terms from inspiring English sources

Some, like Dennis Ross, who has served five Presidents, can think only in incremental terms.

After comparing the abovementioned costs and outcomes with the no-treatment strategy in incremental terms (ICER), the single-tablet regimen was shown to be the most cost-effective therapeutic choice, with an ICER of €22,017.00 versus €26,558.00, which is well below the threshold values considered to be acceptable.

Comparing the above mentioned costs and outcomes in incremental terms (ICER) with the no-treatment strategy, the STR appeared to be the most cost-effective therapeutic choice (€22,017), followed by TDF + 3TC + EFV (€24,526), TDF/FTC + nevirapine (€26,416), and TDF + FTC + EFV (€26,558); the remaining strategies have an ICER value varying from €28,000 to €41,000 per QALY.

Comparing the aforementioned costs and QALYs in incremental terms (ICER) with the no-treatment strategy, the STR of TDF/FTC/RPV appears to be the most cost-effective therapeutic choice (€13,655.00), followed by TDF/FTC + RPV (MPR, €15,803.00) and TDF/FTC + efavirenz (EFV) (€16,181.00); the remaining strategies have an ICER value varying from €17,000.00 to €25,000.00 per QALY.

While there was a lot to discover back in the days when the wealthy could tinker in their personal labs, these days experiments are more incremental in terms of the knowledge gained and the complexity of the equipment, but that same intellectual curiosity is driving the work.

The primary outcome of the study is cost-effectiveness, measured in terms of incremental cost per reduction of the severity of depression achieved and in incremental costs per quality adjusted life years (QALYs) gained.

Incremental benefits in terms of reduction in the incidence of HPV 6, 11, 16 and 18-related diseases (including cervical, vaginal, vulvar, anal, penile, and head and neck carcinomas and genital warts) were assessed.

This will be done both in summary form in terms of incremental cost per QALY, and also using a 'disaggregated' approach where the extra costs are presented alongside the outcome gains in terms of improvements in pain, physical activity, mental well-being etc.

We present the results in terms of incremental costs, incremental LYG and incremental cost per LYG [ 15], first undiscounted and then at a 3%% discount rate.

Though analytic measures are different, it does seem SIF associations are weaker in DCCT/EDIC than in EDC when assessed in terms of incremental association after accounting for historic glycemic control.

Incremental cost-effectiveness will be expressed in terms of incremental costs per QALY gained.